** Shares of Compumedics CMP.AX rise 12.3% to A$0.32, hitting their highest level since Oct. 17
** Medical diagnostics firm expects sales of more than A$55 million ($34.02 million) for fiscal 2025, up from A$52 mln a year ago
** Co also logged sales orders of A$32.8 mln in 1H25 vs A$30.3 mln in 1H24
** Attributes higher sales to U.S. "continuing to provide evidence of accelerating sales growth;" added U.S. orders were up 208% in 1H25 compared to last year
** Stock eyeing its best trading session since early September, if current gains hold
** More than 102,000 shares change hands, 2.4 times the 30-day avg
** Compumedics up 20.8% YTD, including current session's moves
($1 = 1.6166 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.